Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Providers discussing
Why Should We Deprescribe Anticholinergics?
Patient medication
Patient Concerns About Deprescribing: How to Address Them
Patient and psychologist
How to Taper Anticholinergic Medications Safely
Brain image
Are There Guidelines for Deprescribing Anticholinergics?
Patient in counseling
Patient Case Studies: Successful Deprescription of Anticholinergics
Woman taking medication
How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?
Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Medication
CME: Optimizing the Utility of Muscarinic Acetylcholine Receptor Activators in Clinical Practice
Medication
CME: Interpreting the Latest Clinical Data and Treatment Implications for Approved and Emerging Muscarinic Acetylcholine Receptor Activators in Schizophrenia
Medication
CME: Understanding Muscarinic Acetylcholine Receptor Activation as a Therapeutic Target in Schizophrenia

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy